What were Becton Dickinson's primary business segments in 2009?

While the 10-K filing provides detailed information, Becton Dickinson's business historically has been organized into segments such as Medical, which includes medication management and safety solutions; Diagnostic, focused on specimen collection and diagnostic instrument systems; and International operations.

What were the key financial performance indicators highlighted in the 2009 10-K?

The report would typically detail revenue growth, gross profit margins, operating income, net income, and earnings per share for the fiscal year. Investors should pay close attention to the trends in these metrics and the narrative provided in the MD&A section to understand the underlying reasons for performance.

What major risks did Becton Dickinson identify in its 2009 filing?

Common risks for companies like Becton Dickinson in this period could include regulatory changes, competition, product recalls, economic downturns affecting healthcare spending, currency fluctuations, and integration risks from acquisitions. The specific risks detailed in Item 1A of the filing are essential for a complete understanding.

How did Becton Dickinson address its financial condition and liquidity in the 2009 report?

The MD&A section (Item 7) would discuss the company's cash flows, debt levels, access to credit facilities, and its strategies for managing working capital. Investors should look for information regarding the company's ability to fund its operations, capital expenditures, and any potential impact from prevailing economic conditions.

BDX 10-K FY2009 Annual Report — Revenue, Net Income, EPS

Summary

Becton Dickinson & Co. (BDX) filed its 2009 10-K report on November 24, 2009, covering the fiscal year ended September 29, 2009. This filing provides a comprehensive overview of the company's business, financial performance, and strategic outlook. Investors can gain insights into the company's operations across its key segments, which typically include medical, diagnostic, and surgical products, by reviewing the "Business" section. The "Management's Discussion and Analysis of Financial Condition and Results of Operations" is crucial for understanding the drivers of revenue and profitability, as well as the company's liquidity and capital resources.

Financial Highlights

55 data points

Beta

Revenue

$6.99B

0.5% Gross Margin

Net Income

$1.23B

0.2% Net Margin

EPS (Diluted)

$4.99

Total Assets

$9.30B

Cash & Equivalents

$1.39B

Free Cash Flow

$1.07B

Financial Statements

Beta

Revenue	$6.99B
Cost of Revenue	$3.31B
Gross Profit	$3.68B
R&D Expenses	$404.57M
SG&A Expenses	$1.68B
Operating Expenses	$5.40B
Operating Income	$1.59B
Interest Expense	$40.39M
Net Income	$1.23B
EPS (Basic)	$5.12
EPS (Diluted)	$4.99
Shares Outstanding (Basic)	240.48M
Shares Outstanding (Diluted)	246.80M

Key Highlights

1The 10-K report details Becton Dickinson's business operations, encompassing its various product segments and global reach.
2Key financial data and trends for the fiscal year ending September 29, 2009, are presented, offering insights into revenue, profitability, and expense management.
3The Management's Discussion and Analysis (MD&A) section is vital for understanding the company's financial condition, including its liquidity, capital resources, and the factors influencing its results of operations.
4Risk factors are outlined, providing investors with potential challenges and uncertainties that could impact the company's future performance.
5Information on legal proceedings, properties, and corporate governance practices is included, offering a broader view of the company's operational and structural aspects.
6Details on market risks and quantitative disclosures related to market risk exposures are provided, allowing investors to assess the company's sensitivity to market fluctuations.

BECTON DICKINSON & CO Annual Report, Year Ended Sep 30, 2009

Summary

Financial Highlights

Key Highlights

Frequently Asked Questions